Financhill
Back

Veracyte Quote, Financials, Valuation and Earnings

Veracyte Price Quote

$40.93
+0.04 (+4.76%)
(Updated: December 21, 2024 at 5:52 AM ET)

Veracyte Key Stats

Buy
63
Veracyte (VCYT) is a Buy

Day range:
$38.44 - $41.38
52-week range:
$18.61 - $46.00
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
7.29
P/B ratio:
2.69%

Volume:
1.8M
Avg. volume:
845K
1-year change:
48.96%
Market cap:
$3.2B
Revenue:
$361.1M
EPS:
$-0.15

How Much Does Veracyte Make?

Data Unavailable

Is Veracyte Growing As A Company?

Data Unavailable

Veracyte Stock Price Performance

  • Did Veracyte Stock Go Up Last Month?
    Veracyte share price went up by 4.31% last month
  • Did VCYT's Share Price Rise Over The Last Year?
    VCYT share price rose by 48.96% over the past 1 year

What Is Veracyte 52-Week High & Low?

  • What Is Veracyte’s 52-Week High Share Price?
    Veracyte has traded as high as $46.00 over the past 52 weeks
  • What Is Veracyte’s 52-Week Low Share Price?
    Veracyte has traded as low as $18.61 over the past 52 weeks

Veracyte Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Veracyte?

Data Unavailable

Is Veracyte Cash Flow Positive?

Data Unavailable

Veracyte Return On Invested Capital

Data Unavailable

Veracyte Earnings Date & Stock Price

  • What Is Veracyte's Stock Price Today?
    A single share of VCYT can be purchased today for 40.89
  • What Is Veracyte’s Stock Symbol?
    Veracyte trades on the nasdaq under the ticker symbol: VCYT
  • When Is Veracyte’s Next Earnings Date?
    The next quarterly earnings date for Veracyte is scheduled on February 21, 2025
  • When Is VCYT's next ex-dividend date?
    Veracyte's next ex-dividend date is December 22, 2024
  • How To Buy Veracyte Stock?
    You can buy Veracyte shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Veracyte Competitors

  • Who Are Veracyte's Competitors?
    Below is a list of companies who compete with Veracyte or are related in some way:
    • Applied DNA Sciences Inc (APDN)
    • Fonar Corp (FONR)
    • OncoCyte Corp (OCX)
    • ProPhase Labs Inc (PRPH)
    • XWELL Inc (XWEL)

Veracyte Dividend Yield

Data Unavailable

Veracyte Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 98.82%
Revenue: 28.58% 5.49%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 2
Sell Recommendations: 1
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable